The study is designed to assess the pharmacokinetics of Silo’s dissolvable ketamine-based injectable implant, SP-26, in a minipig model. SP-26 is being developed as a self-administered, non-opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback